Can I Take Zinc with Oral Micronized Progesterone (Prometrium)?

Zinc is a common over-the-counter mineral supplement, taken for immune support, skin health, or general nutrition. Oral micronized progesterone (brand name Prometrium) is an FDA-approved bioidentical progesterone capsule, prescribed as part of hormone replacement therapy (HRT) to protect the uterine lining in women taking estrogen, and sometimes used off-label for luteal phase support in fertility treatment. This article addresses whether the two can be taken together, and readers seeking broader guidance can review what to eat for best outcomes.

No published clinical trial has directly tested zinc supplementation alongside oral micronized progesterone, and neither the FDA label for Prometrium nor standard drug-interaction references identify a direct pharmacokinetic interaction between the two. That absence of a flagged interaction is a meaningful data point, but it is not the same as a study confirming safety in combination. The more useful question for a woman on long-term HRT is not "does zinc block my progesterone" but "is my zinc dose high enough, or my use long enough, to create a copper-depletion risk that routine HRT lab work would not catch."

The direct answer

Zinc and oral micronized progesterone have no documented direct pharmacokinetic interaction: zinc is not known to change how progesterone is absorbed, metabolized, or cleared from the body. The relevant concerns are pharmacodynamic and indirect, zinc's known ability to interfere with copper absorption at higher, sustained doses, and a plausible but unconfirmed mild influence on hormone-metabolizing enzymes. For most women taking zinc at typical supplemental doses (roughly 15 to 30 mg elemental zinc per day) alongside oral micronized progesterone, the combination is generally considered low risk, and periodic attention to total zinc intake and copper status is a reasonable precaution rather than a response to a proven problem.

Why this combination raises the question at all

The concern here is not one substance blocking the other. It comes from two separate facts about zinc that have nothing specifically to do with progesterone: zinc is a cofactor in enzymes involved in steroid hormone metabolism, and sustained zinc intake above the tolerable upper limit is a recognized cause of copper deficiency. Neither of these facts has been tested specifically in women taking oral micronized progesterone, so what follows below is a mix of established general pharmacology and reasoning by extension, not a body of trial evidence about this specific combination.

What the drug label and interaction databases show

The current FDA prescribing information for Prometrium does not list mineral supplements, including zinc, among its documented drug interactions (FDA label, accessed via Drugs@FDA). Standard commercial interaction checkers likewise do not flag a zinc-progesterone interaction. This is consistent with low risk given decades of overlapping use of both substances, but it should be read as "no interaction has been identified or reported," not as "an interaction has been specifically studied and ruled out." Interaction databases are built largely from case reports and known pharmacokinetic mechanisms; a genuinely novel or subtle interaction between two widely available substances can go unreported for a long time.

The two plausible, unproven hormonal mechanisms

Zinc is a cofactor for several enzymes that participate in steroid hormone metabolism, including aromatase (which converts androgens to estrogens) and 5-alpha reductase (which, among other roles, converts progesterone to its neuroactive metabolite allopregnanolone). Animal and small human studies have examined zinc's effects on these enzymes in other contexts, but this article cannot point to a specific, verified study measuring these effects in women taking oral micronized progesterone, and readers should treat any precise numeric claim about "how much" zinc changes estrogen or allopregnanolone levels in this population as unverified until checked against the primary literature.

Two practical implications follow even without a dedicated trial:

• If zinc modestly limits aromatase activity, the effect described in the pharmacology literature for typical supplemental doses is far weaker than a pharmaceutical aromatase inhibitor, and would not be expected to meaningfully offset estradiol dosing in a woman on combined HRT. This is a plausibility argument based on relative enzyme inhibition potency, not a measured outcome in HRT patients.
• If zinc reduces conversion of progesterone to allopregnanolone, the theoretical result would be a slightly blunted sedative effect from bedtime Prometrium. This has not been studied directly and should be treated as a hypothesis, not an established effect.

The copper depletion question, which is the more concrete concern

This is the part of the picture with the clearest evidence base, even though it is not specific to progesterone users.

Zinc and copper compete for absorption in the intestine. Sustained zinc intake well above the tolerable upper intake level is a recognized cause of copper deficiency, which can present as anemia, low white blood cell counts, and in advanced cases, neurological symptoms such as numbness or gait problems. Case reports of zinc-induced copper deficiency in the medical literature generally describe zinc doses far higher than typical multivitamin-level supplementation, often from misuse of zinc-containing products (such as excess use of zinc-containing denture cream) over many months. The National Institutes of Health Office of Dietary Supplements sets the Tolerable Upper Intake Level for zinc at 40 mg per day for adults (NIH ODS Zinc Fact Sheet).

Estrogen therapy raises ceruloplasmin, the main copper-transport protein in blood, which means a standard serum copper test in a woman on combined HRT can look reassuring even if tissue copper stores are declining. This masking effect is a real limitation of relying on routine bloodwork alone, though it has not been specifically quantified for women taking oral micronized progesterone with zinc; it is drawn from the general physiology of estrogen's effect on ceruloplasmin.

What is established, what is plausible, and what is not established

Established:

• No pharmacokinetic interaction between zinc and oral micronized progesterone has been identified in the FDA label or standard interaction references.
• Sustained zinc intake above the tolerable upper intake level (40 mg/day for adults) is a recognized, general cause of copper deficiency, independent of progesterone use.
• Zinc is a cofactor in enzymes that participate in steroid hormone metabolism generally.

Plausible but unproven:

• That typical supplemental zinc doses (15-30 mg/day) meaningfully alter estrogen or allopregnanolone levels in women taking oral micronized progesterone.
• That estrogen-driven changes in ceruloplasmin meaningfully mask early copper depletion specifically in women on combined HRT who also take zinc.

Not established:

• Any specific numeric effect size for zinc's influence on progesterone metabolism, testosterone, or estrogen levels in women taking oral micronized progesterone. Any such figure appearing elsewhere online should be verified against the original study before being treated as fact.
• Whether dose-separation timing changes clinical outcomes for this combination; the rationale for separation below is precautionary, not outcome-tested.

Evidence-status interaction assessment: zinc and oral micronized progesterone

Practical approach for most women on HRT

For a woman taking oral micronized progesterone (typically 100-200 mg nightly, taken with food per the label) alongside a standard multivitamin-level zinc supplement (roughly 15-30 mg elemental zinc/day), there is no specific reason established in the literature to avoid the combination. A reasonable, low-cost approach:

• Take zinc with a daytime meal and progesterone at bedtime with a small fat-containing snack, which creates natural separation without requiring precise timing.
• Keep total elemental zinc intake, including from multivitamins and fortified foods, below the 40 mg/day upper limit unless a clinician has specifically recommended a higher therapeutic dose for a diagnosed deficiency or condition.
• If zinc use is long-term (roughly a year or more) or the dose regularly approaches 25-40 mg/day, ask the prescriber about adding serum copper and ceruloplasmin to routine HRT lab monitoring, since these are not part of standard follow-up otherwise.
• Watch for fatigue, unusual pallor, frequent infections, or new numbness/tingling, and report these promptly rather than attributing them to HRT alone.

Special situations

Women taking high-dose zinc for a diagnosed condition (for example, Wilson disease): Zinc is used at much higher doses (around 150 mg/day) as part of copper-chelation therapy in Wilson disease. In this setting, copper monitoring is already a core part of care managed by a hepatologist or metabolic specialist, and the underlying copper metabolism is fundamentally different from a woman taking zinc for general nutrition. The progesterone interaction question does not change, but the copper-monitoring framework for these patients should be set by the specialist managing the underlying condition, not by the general recommendations above.

Women using progesterone for fertility or luteal phase support: No published trial has shown that zinc supplementation improves progesterone receptor activity or fertility outcomes in this setting. Any claim to that effect should be treated as unverified.

Vaginal or other non-oral progesterone formulations: These bypass first-pass liver metabolism, which makes a metabolic interaction with zinc even less plausible, though this has not been studied directly either.

When to contact your prescriber

Contact your prescriber or pharmacist if your total elemental zinc intake regularly exceeds 40 mg/day, if you have taken zinc and progesterone together for more than about a year without any copper-related labs, or if you develop new fatigue, easy bruising, frequent infections, or numbness/tingling. These symptoms warrant a complete blood count plus serum copper and ceruloplasmin rather than self-adjustment of either supplement. This article does not provide individualized dosing advice; any change to prescribed progesterone or to zinc dosing should go through the clinician managing your hormone therapy.